ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/22/2025
Back to search
Official data from USPTO
NEPHRON PHARMACEUTICALS CORPORATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
01/23/2025
Trademark type
Combined
Nice classes
5
Filing date
08/29/2011
Registration date
12/25/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2022
Last transaction
01/23/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/30/1997
First use in commerce
09/30/1997
Drawing code
3
Owner type
03
Owner location
West Columbia, SC
Examiner
SHOSHO II, ERNEST
Law office
M80
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the phrase "nephron pharmaceuticals corporation" next to a design comprising beakers.
Holders and representatives
Holders
N. C. (pessoa física)
N. C. (pessoa física)
Representatives
E. Eric Mills Nexsen Pruet, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
Publications
History of USPTO decisions and trademark events.
45 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/07/2022
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/07/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/07/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/16/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/16/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/16/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
05/06/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/25/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/08/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/08/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/08/2019
E815
TEAS SECTION 8 & 15 RECEIVED
06/25/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/25/2017
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/13/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
12/25/2012
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
11/15/2012
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/15/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/13/2012
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
11/09/2012
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/22/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/27/2012
PUBO
PUBLISHED FOR OPPOSITION
03/27/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/07/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/17/2012
ALIE
ASSIGNED TO LIE
02/16/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
02/01/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/01/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
02/01/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/01/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/01/2012
GNRT
NON-FINAL ACTION E-MAILED
02/01/2012
CNRT
NON-FINAL ACTION WRITTEN
02/01/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/21/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/16/2011
GNRT
NON-FINAL ACTION E-MAILED
12/16/2011
CNRT
NON-FINAL ACTION WRITTEN
12/16/2011
DOCK
ASSIGNED TO EXAMINER
12/16/2011
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
09/02/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2011
NWAP
NEW APPLICATION ENTERED
09/01/2011
Continuous trademark protection
Get notified about every new filing that threatens NEPHRON PHARMACEUTICALS CORPORATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.